144 related articles for article (PubMed ID: 34837764)
1. Isolation and structural elucidation of bioactive obovatol dimeric neolignans from the bark of Magnolia officinalis var. biloba.
Xu K; Ma J; Li C; Li C; Zang Y; Sun X; Chen X; Wang X; Zhang D
Phytochemistry; 2022 Feb; 194():113020. PubMed ID: 34837764
[TBL] [Abstract][Full Text] [Related]
2. New obovatol trimeric neolignans with NO inhibitory activity from the leaves of Magnolia officinalis var. biloba.
Vu VT; Liu XQ; Nguyen MT; Lin YL; Kong LY; Luo JG
Bioorg Chem; 2020 Mar; 96():103586. PubMed ID: 31982819
[TBL] [Abstract][Full Text] [Related]
3. Novel oligomeric neolignans with PTP1B inhibitory activity from the bark of Magnolia officinalis var. biloba.
Li C; Li CJ; Xu KL; Ma J; Huang JW; Ye F; Zang YD; Zhang DM
Bioorg Chem; 2020 Nov; 104():104319. PubMed ID: 33011531
[TBL] [Abstract][Full Text] [Related]
4. New oligomeric neolignans from the leaves of Magnolia officinalis var. biloba.
Vu VT; Xu XJ; Chen K; Nguyen MT; Nguyen BN; Pham GN; Kong LY; Luo JG
Chin J Nat Med; 2021 Jul; 19(7):491-499. PubMed ID: 34247772
[TBL] [Abstract][Full Text] [Related]
5. Chiral separation and bioactivities of six pairs of enantiomeric dilignans from Magnolia officinalis var. biloba.
Zang YD; Zang CX; Tian JY; Xu KL; Li C; Li CJ; Yang Y; Ye F; Zhang D; Zhang DM; Ma J
Phytochemistry; 2024 Mar; 219():113964. PubMed ID: 38184162
[TBL] [Abstract][Full Text] [Related]
6. Magmenthanes A-H: Eight new meroterpenoids from the bark of Magnolia officinalis var. Biloba.
Li C; Li CJ; Ma J; Huang JW; Wang XY; Wang XL; Ye F; Zhang DM
Bioorg Chem; 2019 Jul; 88():102948. PubMed ID: 31054429
[TBL] [Abstract][Full Text] [Related]
7. Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity.
Ni HF; Cai X; Qiu X; Liu L; Ma X; Wan L; Ye H; Chen L
Fitoterapia; 2020 Nov; 147():104769. PubMed ID: 33152462
[TBL] [Abstract][Full Text] [Related]
8. Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi.
Choi NH; Choi GJ; Min BS; Jang KS; Choi YH; Kang MS; Park MS; Choi JE; Bae BK; Kim JC
J Appl Microbiol; 2009 Jun; 106(6):2057-63. PubMed ID: 19245403
[TBL] [Abstract][Full Text] [Related]
9. Substituted dineolignans from Magnolia garrettii.
Schuehly W; Voith W; Teppner H; Kunert O
J Nat Prod; 2010 Aug; 73(8):1381-4. PubMed ID: 20677809
[TBL] [Abstract][Full Text] [Related]
10. Magterpenoids A-C, Three Polycyclic Meroterpenoids with PTP1B Inhibitory Activity from the Bark of Magnolia officinalis var. biloba.
Li C; Li CJ; Ma J; Chen FY; Li L; Wang XL; Ye F; Zhang DM
Org Lett; 2018 Jun; 20(12):3682-3686. PubMed ID: 29863363
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-inducing and antitumor activity of neolignans isolated from Magnolia officinalis in HeLa cancer cells.
Youn UJ; Fatima N; Chen QC; Chae S; Hung TM; Min BS
Phytother Res; 2013 Sep; 27(9):1419-22. PubMed ID: 23192855
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Neolignans and Other Compounds from Magnolia grandiflora L.: Isolation and Antiplasmodial Activity.
Latif A; Du Y; Dalal SR; Fernández-Murga ML; Merino EF; Cassera MB; Goetz M; Kingston DGI
Chem Biodivers; 2017 Sep; 14(9):. PubMed ID: 28621040
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic lignans from the stem bark of Magnolia officinalis.
Youn UJ; Chen QC; Jin WY; Lee IS; Kim HJ; Lee JP; Chang MJ; Min BS; Bae KH
J Nat Prod; 2007 Oct; 70(10):1687-9. PubMed ID: 17918910
[TBL] [Abstract][Full Text] [Related]
14. Biphenyl-type neolignans from Magnolia officinalis and their anti-inflammatory activities.
Kuo WL; Chung CY; Hwang TL; Chen JJ
Phytochemistry; 2013 Jan; 85():153-60. PubMed ID: 23017219
[TBL] [Abstract][Full Text] [Related]
15. Structural elucidation and neuroprotective activities of lignans from the flower buds of
Ma Q; Wei R; Zhang X; Sang Z; Dong J
Z Naturforsch C J Biosci; 2021 Mar; 76(3-4):147-152. PubMed ID: 33098637
[TBL] [Abstract][Full Text] [Related]
16. A new dimeric neolignan from Magnolia grandiflora L. seeds.
Li HM; Zhao SR; Huo Q; Ma T; Liu H; Lee JK; Hong YS; Wu CZ
Arch Pharm Res; 2015 Jun; 38(6):1066-71. PubMed ID: 25193624
[TBL] [Abstract][Full Text] [Related]
17. A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses anxiolytic-like activity with neuroprotective effect through the modulation of CB1 receptor.
Borgonetti V; Governa P; Manetti F; Miraldi E; Biagi M; Galeotti N
J Pharm Pharmacol; 2021 Aug; 73(9):1161-1168. PubMed ID: 33950239
[TBL] [Abstract][Full Text] [Related]
18. Phenolic constituents from the stem bark of Magnolia officinalis.
Shen CC; Ni CL; Shen YC; Huang YL; Kuo CH; Wu TS; Chen CC
J Nat Prod; 2009 Jan; 72(1):168-71. PubMed ID: 19086868
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.
Lee YK; Yuk DY; Kim TI; Kim YH; Kim KT; Kim KH; Lee BJ; Nam SY; Hong JT
J Nat Med; 2009 Jul; 63(3):274-82. PubMed ID: 19343477
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory neolignans from the roots of Magnolia officinalis.
Shih HC; Kuo PC; Wu SJ; Hwang TL; Hung HY; Shen DY; Shieh PC; Liao YR; Lee EJ; Gu Q; Lee KH; Wu TS
Bioorg Med Chem; 2016 Apr; 24(7):1439-45. PubMed ID: 26928286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
